UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 401 - 450 of 1748

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Office Cystoscopy and Transrectal Ultrasound-Guided Prostate Biopsies Pose Minimal Risk: Prospective Evaluation of 921 Procedures - Abstract
Thursday, 21 May 2009
Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
read more

Gemcitabine and Paclitaxel Every 2 Weeks in Patients with Previously Untreated Urothelial Carcinoma - Abstract
Tuesday, 19 May 2009
San Camillo Forlanini Hospital, Rome, Italy.
read more

Systemic Therapy of Advanced Urothelial Cancer - Abstract
Tuesday, 19 May 2009
4HWCRC, 4100 John R, Detroit, MI 48201, USA.
read more

The Effects of Neoadjuvant Chemotherapy and Chemo-Radiation Therapy on MRI Staging in Invasive Bladder Cancer: Comparative Study Based on the Pathological Examination of Whole Layer Bladder Wall - Abstract
Monday, 18 May 2009
Department of Urology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan,
read more

Defining the Clinical Target Volume for Bladder Cancer Radiotherapy Treatment Planning - Abstract
Monday, 18 May 2009
Gloucestershire Oncology Centre, Cheltenham General Hospital, Cheltenham, United Kingdom.
read more

Long-Term Efficacy of Maintenance Bacillus Calmette-Guérin Versus Maintenance Mitomycin C Instillation Therapy in Frequently Recurrent TaT1 Tumours without Carcinoma In Situ: A Subgroup Analysis of the Prospective, Randomised FinnBladder I Study with a 20-Year Follow-Up - Abstract
Monday, 18 May 2009
Helsinki University Hospital, Department of Urology, Helsinki, Finland.
read more

Intravesical Mitomycin C Combined with Hyperthermia for Patients with T1G3 Transitional Cell Carcinoma of the Bladder - Abstract
Monday, 18 May 2009
Bnai Zion Medical Center and the Faculty of Medicine, Technion Israeli Institute of Technology, Haifa, Israel.
read more

Comparison Between a Serous-Lined Extramural Tunnel and T-limb Ileal Procedure as an Antireflux Technique in Orthotopic Ileal Substitutes: A Prospective Randomized Trial - Abstract
Friday, 15 May 2009
Urology & Nephrology Center, Mansoura University, Mansoura, Egypt.
read more

Outcomes of Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer with Prostatic Involvement on Final Pathology - Abstract
Friday, 15 May 2009
Vanderbilt University Medical Center, Department of Urologic Surgery, Nashville, TN, USA.
read more

A Single-Institution Experience with Induction and Maintenance Intravesical Docetaxel in the Management of Non-Muscle-Invasive Bladder Cancer Refractory to Bacille Calmette-Guérin Therapy - Abstract
Friday, 15 May 2009
Department of Urology, Columbia University Medical Center, New York.
read more

Urinary Calreticulin in the Diagnosis of Bladder Urothelial Carcinoma - Abstract
Friday, 15 May 2009
Department of Urology, Shiga University of Medical Science, Otsu, Shiga, Japan.
read more

Identification of Novel MicroRNA Targets Based on MicroRNA Signatures in Bladder Cancer - Abstract
Thursday, 14 May 2009
Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
read more

Combined Effect of Smoking and Inherited Polymorphisms in Arylamine N-Acetyltransferase 2, Glutathione S-Transferases M1 and T1 on Bladder Cancer in a Tunisian Population - Abstract
Thursday, 14 May 2009
Laboratory of Genetic, Immunology and Human Pathology, Faculty of Sciences of Tunis, El Mannar I. 2092, Tunis, Tunisia.
read more

Preoperative T Staging of Urinary Bladder Cancer: Does Diffusion-Weighted MRI have Supplementary Value? - Abstract
Thursday, 14 May 2009
Department of Radiology, Gifu University Hospital, 1-1 Yanagido, Gifu, Japan.
read more

Bladder Conservation Treatment in the Elderly Population: Results and Prognostic Factors of Muscle-Invasive Bladder Cancer - Abstract
Thursday, 14 May 2009
Departments of Radiation Oncology, Urology, and Medicine (Division of Medical Oncology), McGill University Health Center, Montreal, Canada.
read more

Safety of Active Surveillance Program for Recurrent Nonmuscle-Invasive Bladder Carcinoma - Abstract
Wednesday, 13 May 2009
Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
read more

The Use of Short Tandem Repeat Profiling to Characterize Human Bladder Cancer Cell Lines - Abstract
Wednesday, 13 May 2009
Departments of Urology and Clinical Cancer Prevention (ALS), University of Texas M. D. Anderson Cancer Center, Houston, Texas.
read more

Early and Late Urodynamic Assessment of Padua Ileal Bladder - Abstract
Wednesday, 13 May 2009
"Regina Elena" National Cancer Institute, Rome, Italy.
read more

A Robust Methodology to Study Urine MicroRNA as Tumor Marker: MicroRNA-126 and MicroRNA-182 are Related to Urinary Bladder Cancer - Abstract
Wednesday, 13 May 2009
Kompetenzzentrum für Drug Design und Target Monitoring, Lübeck, Germany.
read more

Laparoscopic vs Open Radical Nephroureterectomy for Upper Urinary Tract Urothelial Cancer: Oncological Outcomes and 5-Year Follow-Up - Abstract
Wednesday, 13 May 2009
Department of Urology and Kidney Transplantation, Martin-Luther University, Halle/Saale, Germany.
read more

Trends in Pelvic Lymphadenectomy at the Time of Radical Cystectomy: 1988 to 2004 - Abstract
Tuesday, 12 May 2009
Department of Urology, University of California, Davis Medical Center, Sacramento, California.
read more

A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219) - Abstract
Tuesday, 12 May 2009
University of California at Davis, Sacramento, California.
read more

Sex-Specific Hormone Receptors in Urothelial Carcinomas of the Human Urinary Bladder: A Comparative Analysis of Clinicopathological Features and Survival Outcomes According to Receptor Expression - Abstract
Tuesday, 12 May 2009
Department of Urology, Ministry of Health Yildirim Beyazit Diskapi Educational and Research Hospital, Ankara, Turkey.
read more

EGFR Pathway Polymorphisms and Bladder Cancer Susceptibility and Prognosis - Abstract
Tuesday, 12 May 2009
Department of Community and Family Medicine, Section of Biostatistics and Epidemiology, Dartmouth Medical School, Lebanon, NH 03756.
read more

Peritoneal Tuberculosis and Granulomatous Hepatitis Secondary to Treatment of Bladder Cancer with Bacillus Calmette-Guérin - Abstract
Monday, 11 May 2009
Department of Gastroenterology, Bakirkoy Training and Research Hospital, Istanbul, Turkey.
read more

Tuberculous Epididymitis Following Intravesical Bacillus Calmette-Guérin Immunotherapy - Abstract
Monday, 11 May 2009
Department of Urologic Sciences, University of British Columbia (Island Medical Program), Victoria, BC, Canada.
read more

Comparison of ImmunoCyt, UroVysion, and Urine Cytology in Detection of Recurrent Urothelial Carcinoma: A "Split-Sample" Study - Abstract
Monday, 11 May 2009
Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
read more

In Vivo Studies on the Availability and Toxicity of Antisense Oligonucleotides in Bladder Cancer - Abstract
Monday, 11 May 2009
Department of Urology, University of Lübeck, Lübeck, Germany.
read more

Beyond the Abstract - Diagnostic Accuracy of Transitional Cell Carcinoma on Multidetector Computerized Tomography Urography in Patients With Gross Hematuria
Friday, 08 May 2009
BERKELEY, CA (UroToday.com) - Our current study proves that multidetector computerized tomography urography (MDCTU) is sensitive and accurate for transitional cell carcinoma (TCC) of the urinary tract in hematuria patients.
Login to read more...

Comparison of Oncologic Outcomes for Open and Laparoscopic Nephroureterectomy: A Multi-Institutional Analysis of 1249 Cases - Abstract
Friday, 08 May 2009
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada.
read more

Recurrence at Three Months and High-Grade Recurrence as Prognostic Factor of Progression in Multivariate Analysis of T1G2 Bladder Tumors - Abstract
Friday, 08 May 2009
Department of Urology, Hospital Universitario Puerto Real, Cádiz, Spain.
read more

Updated Results of Bladder-Sparing Trimodality Approach for Invasive Bladder Cancer - Abstract
Friday, 08 May 2009
Department of Radiation Oncology, Hospital Universitario de la Princesa, Madrid, Spain.
read more

The Role of Biotransformation Enzymes in the Development of Renal Injury and Urothelial Cancer Caused by Aristolochic Acid: Urgent Questions and Difficult Answers - Abstract
Tuesday, 05 May 2009
Department of Biochemistry, Faculty of Sciences, Charles University, Albertov 2030, Prague, Czech Republic.
read more

Laparoscopic Radical Cystectomy: Current Status, Outcomes, and Patient Selection - Abstract
Monday, 04 May 2009
Department of Urology, Center for Laparoscopic and Robotic Surgery, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
read more

AUA 2009 - Bladder Cancer: Superficial - Racial Differences in Treatment and Outcomes Among Patients with Early Stage Bladder Cancer - Session Highlights
Thursday, 30 April 2009
CHICAGO, IL, USA (UroToday.com) - This study explored the extent to which disparities in mortality are attributable to the urologist among patients with early stage bladder cancer.
Login to read more...

AUA 2009 - Bladder Cancer: Superficial - Hexaminolevulinate Fluorescence Cystoscopy Improves Detection and Resection of Papillary Bladder Cancer Lesions and Reduces Early Recurrences - Session Highlights
Thursday, 30 April 2009
CHICAGO, IL, USA (UroToday.com) - This study sought to compare fluorescence guided and white light cystoscopy in the detection of non-muscle invasive papillary bladder tumors, and to compare early recurrence rates following HAL or white light resection of identified tumors.
Login to read more...

AUA 2009 - Bladder Cancer: Invasive Metastatic Disease - Detection of Circulating Tumour Cells with the Cellsearch System® in Peripheral Blood from Patients with Advanced Bladder Cancer - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - The CellSearch System®(CSS) is a new automated, standardized enrichment and immunocytochemical detection system for circulating tumor cells (CTCs) in the peripheral blood.
Login to read more...

AUA 2009 - Bladder Cancer: Invasive Metastatic Disease - Significance of Distal Ureteral Margin at Radical Cystectomy for Urothelial Carcinoma - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - Patients undergoing radical cystectomy are at risk for upper tract recurrence.
Login to read more...

AUA 2009 - Bladder Cancer: Superficial - NMP22 is Predictive of Recurrence in High Risk Superficial Bladder Cancer Patients - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - This study assessed the use of NMP22 to predict which high-risk superficial bladder cancer patients will have recurrence, progression or disease-related death and compared this to standard urine cytology.
Login to read more...

AUA 2009 - Bladder Cancer: Superficial - Intraoperative Stenting of the Upper Urinary Tract is not Necessary After Resection of the Ureteric Orifice During Transurethral Resection of the Bladder - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - These researchers evaluated the common practice of placing a double J stent when transurethral resection of a bladder tumor (TUR-B) includes resection of the ureteric orifice.
Login to read more...

AUA 2009 - A Review of AUA Clinical Guidelines on the Management of Non-Muscle Invasive Bladder Cancer - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - A panel on non-muscle invasive bladder cancer (NMIBC) was moderated by Dr. Mark Soloway.
Login to read more...

AUA 2009 - NMP22 is Predictive of Recurrence in High-Risk Superficial Bladder Cancer Patients - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report, the authors suggests that NMP22 might be useful for predicting which patients will have future tumor recurrence but not progression or survival.
Login to read more...

AUA 2009 - Société Internationale d’Urologie (SIU) Lecture - Lymph Node Dissection in Urologic Cancers: Treatment or Staging Only - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - Professor Joachim Thuroff discussed lymph node dissection (LND) in urologic cancers.
Login to read more...

AUA 2009 - NMP22 is Predictive of Recurrence in High Risk Superficial Bladder Cancer Patients - Poster
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - We assessed the use of urinary NMP22 to predict which high risk superficial UC patients will have recurrence, progression or disease related death and compared this to standard urine cytology.
Login to read more...

AUA 2009 - New Approaches to Management of Cancer Invasiveness: Personalized Therapy and Drug Discovery in Urologic Cancer - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - Dr. Dan Theodorescu presented the concept of personalized cancer therapy.
Login to read more...

AUA 2009 - Bladder Cancer: Detection and Screening - Combinations of Several Urinary Tumour Markers Can Reduce Follow-up Cystoscopies in Transitional Cell Carcinoma Patients - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - The aim of this presentation was to investigate if a combination of several tumor markers might be used to safely reduce the number of cystoscopies in patients with transitional cell carcinoma (TCC).
Login to read more...

AUA 2009 - Bladder Cancer: Detection and Screening - Molecular Tumor Marker Tests for Bladder Cancer Screening are Influenced by Various Confounders - Interim Data of the Prospective Study UroScreen - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - This presentation was on UroScreen, a prospective study for early diagnosis of bladder cancer in 1,772 chemical workers formerly exposed to aromatic amines.
Login to read more...

AUA 2009 - Bladder Cancer: Basic Research - Quantification of Sunitinib's Antitumor Effects in a Localized Orthotopic Bladder Cancer Model - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - This study reported on the effects of sunitinib on tumor growth rate, tumor volume, and vascular endothelial growth factor (VEGF) receptor (VEGFR2) expression in an orthotopic mouse bladder cancer model.
Login to read more...

AUA 2009 - Bladder Cancer: Basic Research - Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - This presentation reported on the effect of the mTOR inhibitor everolimus (RAD001) on human bladder cancer cells in vitro and in vivo.
Login to read more...

AUA 2009 - Bladder Cancer: Basic Research - Clinical Significance of False Positive Mucosa by Photodynamic Diagnosis-Possible Existence of Premalignant Genomic Alterations - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - Photodynamic diagnosis (PDD) by the fluorescence cystoscopy has become a novel tool not only for decreasing the recurrence in non-invasive bladder cancer.
Login to read more...

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- by Mitsuru Takeuchi, MD

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- by Masaharu Inoue, MD, et al.

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- by Christine M. Mueller, DO, et al.

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer and the Aluminium Industry: A Review

Invasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts